PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL VARICELLA VACCINATION IN THE UNITED KINGDOM

被引：0
|
作者：
Jamet, N. [1 ]
George, M. [2 ]
Shah, H. A. [3 ]
Oliyide, A. [3 ]
Zerda, I [4 ]
Cristeau, O. [5 ]
Casabona, G. [1 ]
机构：
[1] GSK, Wavre, Belgium
[2] Hari Thrivikramji, Wavre, Belgium
[3] GSK, London, England
[4] Creativ Ceut, Krakow, Poland
[5] Creativ Ceut, Paris, France
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH161
引用
收藏
页码：S221 / S222
页数：2
相关论文
共 50 条
  • [21] Universal varicella vaccination in Denmark: Modeling public health impact, age- shift, and cost-effectiveness (vol 3, e0001743, 2023)
    Burgess, Colleen
    Samant, Salome
    Lefevre, Thomas
    Larsen, Carsten Schade
    Pawaskar, Manjiri
    PLOS GLOBAL PUBLIC HEALTH, 2023, 3 (09):
  • [22] An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
    Largeron, Nathalie
    Petry, Karl Ulrich
    Jacob, Jorge
    Bianic, Florence
    Anger, Delphine
    Uhart, Mathieu
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 85 - 98
  • [23] The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies
    Azzari, C.
    Baldo, V
    Giuffrida, S.
    Gani, R.
    O'Brien, E.
    Alimenti, C.
    Daniels, V. J.
    Wolfson, L. J.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 273 - 283
  • [24] Cost-effectiveness of varicella vaccination of healthcare workers
    Chodick, G
    Ashkenazi, S
    Livni, G
    Lerman, Y
    VACCINE, 2005, 23 (43) : 5064 - 5072
  • [25] Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
    Clements, Karen M.
    Meier, Genevieve
    McGarry, Lisa J.
    Pruttivarasin, Narin
    Misurski, Derek A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1171 - 1180
  • [26] Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States
    Pawaskar, Manjiri
    Fergie, Jaime
    Harley, Carolyn
    Samant, Salome
    Veeranki, Phani
    Diaz, Oliver
    Conway, James H.
    PLOS ONE, 2022, 17 (06):
  • [27] COST-EFFECTIVENESS OF A ROUTINE VARICELLA VACCINATION PROGRAM FOR UNITED-STATES CHILDREN
    LIEU, TA
    COCHI, SL
    BLACK, SB
    HALLORAN, ME
    SHINEFIELD, HR
    HOLMES, SJ
    WHARTON, M
    WASHINGTON, AE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05): : 375 - 381
  • [28] COST-EFFECTIVENESS OF A ROUTINE VARICELLA VACCINATION PROGRAM FOR UNITED-STATES CHILDREN
    LIEU, TA
    COCHI, SL
    BLACK, SB
    HALLORAN, ME
    SHINEFIELD, HR
    HOLMES, SR
    WHARTON, M
    WASHINGTON, AE
    CLINICAL RESEARCH, 1994, 42 (01): : A8 - A8
  • [29] Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach
    Dhankhar, Praveen
    Nwankwo, Chizoba
    Pillsbury, Matthew
    Lauschke, Andreas
    Goveia, Michelle G.
    Acosta, Camilo J.
    Elbasha, Elamin H.
    VALUE IN HEALTH, 2015, 18 (04) : 358 - 367
  • [30] Screening and Vaccination Against Measles and Varicella Among Health Care Workers: A Cost-effectiveness Analysis
    Lee, Ji-Suk
    Jeong, Oh
    Yang, Hyunju
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2021, 33 (05) : 508 - 515
12345